Filing Flows › China Pharma Holdings (CPHI) › Q2 2026 › vs Q1 2026
China Pharma Holdings (CPHI) Q2 2026 vs Q1 2026 (quarter over quarter)
China Pharma Holdings's revenue fell $35K (-4%) from $984K in Q1 2026 to $948K in Q2 2026.
China Pharma Holdings, Q2 2026: revenue $948K (-8% year over year), operating margin -151.0%, net loss $1.5M, operating cash flow −$33K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $948K | $984K | −$35K | -4% |
| Net loss | $1.5M | $1.1M | $315K | +28% |
| Costs & expenses | $2.4M | $2.1M | $280K | +13% |
| Operating costs | $2.4M | $2.1M | $279K | +13% |
| Interest & other, net | $26K | $26K | $394 | +2% |
| Cost of revenue | $865K | $698K | $167K | +24% |
| Research & development | $19K | $84K | −$65K | -77% |
| Sales & marketing | $114K | $96K | $18K | +19% |
| General & admin | $1.4M | $1.2M | $151K | +12% |
| Operating cash sources | $1.5M | $1.1M | $315K | +28% |
| Depreciation & amortization | $1.1M | $981K | $121K | +12% |
| Working capital & other | $323K | $107K | $216K | +201% |
| Cash used in operations | $33K | $55K | −$22K | -41% |
| Net loss absorbed | $1.5M | $1.1M | $315K | +28% |
Questions
How much did China Pharma Holdings's revenue grow quarter over quarter in Q2 2026?
China Pharma Holdings's revenue fell $35K (-4%) from $984K in Q1 2026 to $948K in Q2 2026.